STOCK TITAN

MiNK Therapeutics, Inc. (INKT) Total Assets by Year

INKT

MiNK Therapeutics, Inc. closed fiscal year 2025 with $14.2M in total assets, $28.5M in total liabilities and -$14.2M in shareholder equity. This represents an increase of 148.9% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters MiNK Therapeutics, Inc. has filed alongside them.

FY2025 annual
Total Assets $14.2M
Total Liabilities $28.5M
Total Equity -$14.2M
YoY +148.9%
5Y CAGR +25.6%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

INKT Balance Sheet by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
Total Assets$14.2M+148.9%$5.7M+25.7%$4.6M-78.8%$21.5M-46.6%$40.2M+783.4%$4.6M
Total Liabilities$28.5M+12.5%$25.3M+11.9%$22.6M+3.4%$21.9M+32.8%$16.5M-71.8%$58.4M
Total Equity-$14.2M+27.4%-$19.6M-8.5%-$18.1M-4399.2%-$401K-101.7%$23.8M+144.1%-$53.9M

INKT Balance Sheet by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Total Assets$9.6M+287.0%$10.4M+143.2%$14.2M+148.9%$15.0M+102.9%$2.5M-75.9%$4.3M-38.1%$5.7M+25.7%$7.4M-1.2%$10.3M-14.8%$6.9M-58.4%$4.6M-78.8%$7.5M-70.5%
Total Liabilities$23.6M-14.6%$23.1M-11.5%$28.5M+12.5%$28.5M+14.2%$27.7M+2.9%$26.1M-4.2%$25.3M+11.9%$24.9M+18.5%$26.9M+24.5%$27.2M+29.1%$22.6M+3.4%$21.0M+13.7%
Total Equity-$14.0M+44.3%-$12.7M+41.8%-$14.2M+27.4%-$13.5M+23.0%-$25.2M-52.0%-$21.8M-7.4%-$19.6M-8.5%-$17.6M-29.3%-$16.6M-74.6%-$20.3M-353.5%-$18.1M-4399.2%-$13.6M-301.0%

What total assets means

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.

More MiNK Therapeutics, Inc. financials

Frequently Asked Questions

What was MiNK Therapeutics, Inc.'s total assets in fiscal year 2025?

MiNK Therapeutics, Inc. closed fiscal year 2025 with $14.2M in total assets, $28.5M in total liabilities and -$14.2M in shareholder equity.

How fast is MiNK Therapeutics, Inc.'s total assets growing?

MiNK Therapeutics, Inc. (INKT) total assets rose by 148.9% year over year, from $5.7M to $14.2M in fiscal year 2025.

How has MiNK Therapeutics, Inc.'s total assets changed over the years?

Across the 6 fiscal years this page covers, MiNK Therapeutics, Inc. (INKT) total assets went from $4.6M in fiscal year 2020 to $14.2M in fiscal year 2025.

MiNK Therapeutics, Inc. (INKT) reported $9.6M in total assets in Q2 2026. This represents an increase of 287.0% from the same quarter a year earlier.

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what MiNK Therapeutics, Inc. (INKT) reported on that line in every period on record.